Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends release_qhvlx34pn5c7lakz3j6kpkpi3q

by Namgue Hong

Published in Biomedical Engineering Letters by Springer Science and Business Media LLC.

2019   Volume 9, Issue 3, p359-366

Abstract

Photobiomodulation (PBM) is a rapidly growing as an innovative therapeutic modality for various types of diseases in recent years. Neuronal degeneration is irreversible process and it is proven to be difficult to slow down or stop the progression. Pharmacologic approaches to slow neuronal degeneration have been studied, but are limited due to concerns about the side effects. Therefore, it is necessary to develop a new therapeutic approach to stabilize neuronal degeneration and achieve neuronal protection against several neurodegenerative diseases. In this review, we have introduced several previous studies showing the positive effect of PBM over neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and different types of epilepsy. Despite excellent outcomes of animal researches, not many clinical studies are conducted or showed positive outcome of PBM against neurodegenerative disease. To achieve clinical application of PBM against neurodegenerative disorder, determination of exact mechanism and establishment of effective clinical protocol seems to be necessary.
In text/plain format

Archived Content

There are no accessible files associated with this release. You could check other releases for this work for an accessible version.

"Dark" Preservation Only
Save Paper Now!

Know of a fulltext copy of on the public web? Submit a URL and we will archive it

Type  article-journal
Stage   published
Date   2019-06-12
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  2093-9868
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: fde4611b-d4de-47dc-97a5-e80b51109204
API URL: JSON